Aclarion, Inc.

NasdaqCM ACON

Aclarion, Inc. Market Capitalization on February 05, 2025: USD 6.93 M

Aclarion, Inc. Market Capitalization is USD 6.93 M on February 05, 2025, a 15,290.07% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Aclarion, Inc. 52-week high Market Capitalization is USD 13.62 M on January 27, 2025, which is 96.62% above the current Market Capitalization.
Aclarion, Inc. 52-week low Market Capitalization is USD 44.17 K on January 22, 2025, which is -99.36% below the current Market Capitalization.
Aclarion, Inc. average Market Capitalization for the last 52 weeks is USD 5.59 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqCM: ACON

Aclarion, Inc.

CEO	Mr. Brent Ness
IPO Date	April 22, 2022
Location	United States
Headquarters	951 Mariners Island Boulevard
Employees	4
Sector	Healthcare
Industries Biotechnology 3D Printing Clinical Trials Database Medical Instruments Pharmaceuticals Software-as-a-Service (SaaS) Telehealth

Description

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Key trends

Past 5 years